Charles Schwab Investment Management Inc Morphic Holding, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$26.12 - $34.07 $29,959 - $39,078	1,147 Added 0.35%	327,844 $11.2 Million
Q1 2024 May 08, 2024	BUY	$26.64 - $40.31 $193,060 - $292,126	7,247 Added 2.27%	326,697 $11.5 Million
Q4 2023 Feb 06, 2024	BUY	$19.95 - $31.0 $302,721 - $470,394	15,174 Added 4.99%	319,450 $9.23 Million
Q3 2023 Nov 08, 2023	BUY	$21.33 - $59.42 $794,841 - $2.21 Million	37,264 Added 13.96%	304,276 $6.97 Million
Q2 2023 Aug 09, 2023	BUY	$34.33 - $62.11 $1.91 Million - $3.46 Million	55,642 Added 26.32%	267,012 $15.3 Million
Q1 2023 May 11, 2023	BUY	$26.01 - $48.69 $5,514 - $10,322	212 Added 0.1%	211,370 $7.96 Million
Q4 2022 Feb 13, 2023	BUY	$24.14 - $30.37 $109,450 - $137,697	4,534 Added 2.19%	211,158 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $315,532 - $473,653	14,194 Added 7.38%	206,624 $5.85 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $263,055 - $573,151	13,326 Added 7.44%	192,430 $4.18 Million
Q1 2022 May 13, 2022	BUY	$36.25 - $52.02 $168,453 - $241,736	4,647 Added 2.66%	179,104 $7.19 Million
Q4 2021 Feb 11, 2022	BUY	$43.27 - $65.72 $270,004 - $410,092	6,240 Added 3.71%	174,457 $8.27 Million
Q3 2021 Nov 16, 2021	BUY	$53.61 - $67.5 $2.9 Million - $3.65 Million	54,061 Added 47.36%	168,217 $9.53 Million
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $685,524 - $987,198	15,190 Added 15.35%	114,156 $6.55 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $674,439 - $1.92 Million	22,655 Added 29.69%	98,966 $6.26 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $83,087 - $111,872	3,238 Added 4.43%	76,311 $2.56 Million
Q3 2020 Nov 13, 2020	BUY	$22.51 - $30.11 $332,067 - $444,182	14,752 Added 25.29%	73,073 $2 Million
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $158,125 - $369,625	12,500 Added 27.28%	58,321 $1.58 Million
Q1 2020 May 15, 2020	BUY	$10.84 - $20.85 $138,340 - $266,087	12,762 Added 38.6%	45,821 $673,000
Q4 2019 Feb 07, 2020	BUY	$13.02 - $19.5 $5,012 - $7,507	385 Added 1.18%	33,059 $568,000
Q3 2019 Nov 08, 2019	BUY	$17.46 - $29.05 $570,488 - $949,179	32,674 New	32,674 $592,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.7M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account